By Editor , 3 November 2026
Energy per token fails to predict cost per correct AI answer

California – November 02, 2026 -- A local-inference benchmark on an AMD Strix Halo machine found that gemma-3-27b delivers a correct answer for 729 joules at 98% accuracy, while the faster, leaner trinity-nano needs 1,004 joules at 39% accuracy.

By Editor , 2 November 2026
Asthma Campaign Drew 95,000 Views, 62% From Just Four U.S. States

Fairfax, Va. – November 02, 2026 -- Nearly 95,000 social media views of Allergy & Asthma Network's Oral Corticosteroids (OCS) Overexposed campaign were recorded, and 62% of them came from four large states, according to research the nonprofit will present at the American Public Health Association (APHA) 2026 Annual Meeting and Expo in San Antonio, Texas.

By Editor , 27 October 2026
Navigation Use in Sinus Surgery Rises to 41% From 29% Since 2018

United States – October 27, 2026 -- Computer-assisted navigation was used in 41.0% of endoscopic sinus surgeries in 2026, up from 29.2% in 2018, a 40.4% relative increase, according to a Truveta Data analysis of adult patients.

Navigation used in 35.5% of 98,971 procedures over the study period

The analysis covered endoscopic sinus surgeries performed between January 1, 2018, and August 31, 2026. Visits within 90 days of a prior surgery code were counted as a single procedure. Navigation was identified through a specific add-on CPT code.

By Editor , 27 October 2026
CGM Users on Basal Insulin Show 45% Lower One-Year Mortality Risk

Europe – October 27, 2026 -- Continuous glucose monitoring (CGM) was associated with a 45% lower risk of death at one year among adults with type 2 diabetes on basal insulin, according to a study presented at the 2026 European Association for the Study of Diabetes (EASD) Annual Meeting.

The analysis used Truveta Data to track nearly 28,000 adults with type 2 diabetes receiving basal insulin therapy. Researchers combined longitudinal electronic health record (EHR) and mortality data in a target trial emulation that compared CGM users with non-users.

By Editor , 19 October 2026
Antibiotic Use Tied to 1.5x Higher IBS Odds at Age 24, Study Finds

Barcelona – October 18, 2026 -- Young adults who received antibiotics from childhood onward had 1.5 times the odds of irritable bowel syndrome (IBS) at age 24 (95% CI 1.0–2.2), according to a study presented at UEG Week 2026.

Study tracks 2,853 Swedish participants from age 9–11

Researchers analysed data from 2,853 participants in the Swedish BAMSE birth cohort. Antibiotic prescriptions came from the Swedish Prescribed Drug Register, covering 2005, when participants were aged 9–11, until one year before IBS was assessed at age 24.

By Editor , 17 October 2026
MUSC Virtual Nursing Scales to 57 Units, Frees 10.2 FTEs of Capacity

South Carolina – October 17, 2026 -- The Medical University of South Carolina (MUSC) expanded its virtual nursing program from five inpatient units to 57 units across four regions in about two and a half years, and estimates $2.4 million in savings from reduced nurse turnover on early adopter units, according to research from its Telehealth Center of Excellence.

By Editor , 15 October 2026
Local LLM Cost per Right Answer Jumps Up to 64x on Hard Questions

Southern California – October 14, 2026 -- The cheapest local language model for easy questions costs 37 times more per correct answer on hard questions, according to power-metered tests of 27 models on a Strix Halo system. The model, qwen3-30b-a3b-instruct, delivers right answers at 3.6 cents per thousand on easy work. On hard questions the price rises to $1.35 per thousand. Two other models in the 11-model comparison only doubled in cost over the same jump.

By Editor , 14 October 2026
MAPPA Survey: Over Half of PID Patients Diagnosed After Age 18

Maastricht – October 14, 2026 -- More than half of respondents to the MAPPA patient survey received a primary immunodeficiency (PID) diagnosis after age 18, and 28% reported permanent damage at the time of diagnosis, according to preliminary findings Kedrion Biopharma and AIP APS will present at ESID 2026.

By Editor , 13 October 2026
Purina Study: Lean Labradors Lived 1.8 Years Longer

St. Louis – October 12, 2026 -- Labrador Retrievers kept lean from puppyhood lived a median of 1.8 years longer than heavier matched littermates, according to findings from the 14-year Purina Life Span Study, which the Purina Institute is revisiting on the study's 25th anniversary.

By Editor , 5 October 2026
Resero Bio Urine Test Predicts Bladder Cancer Treatment Response

San Carlos, Calif. – October 05, 2026 -- A non-invasive urine test can now predict whether bladder cancer patients will respond to immunotherapy before treatment even begins, according to a Stanford-led study published in Nature Medicine and announced by Resero Bio.